Dr Aseem Malhotra’s address at the recent Reform UK party conference in Birmingham sent ripples through the pharmaceutical sector and political circles alike. Known for his vocal opposition to Covid19
Dr Aseem Malhotra’s address at the recent Reform UK party conference in Birmingham sent ripples through the pharmaceutical sector and political circles alike. Known for his vocal opposition to Covid19
Britain’s pharmaceutical sector has been thrust into sharp focus as the government pledges urgent action to resolve a standoff with multinational drug companies. In the aftermath of several high-profile withdrawals
The United Kingdom’s stock market has experienced its sharpest exodus of investors for more than two decades, with international fund managers increasingly viewing Britain as if it were an emerging
British philanthropist Lady Lynn Forester de Rothschild is exploring the sale of a major stake in The Economist Group in what could be the most significant change to the iconic
A British technological breakthrough has placed the United Kingdom at the forefront of quantum computing innovation. Quantum Motion, a London-based start-up established by academics from Oxford and University College London,
Ministers are poised to unveil ambitious plans to fasttrack a new era of small modular nuclear reactors as part of a landmark UK US deal aiming to cement Britain’s position
Octopus Titan, Britain’s largest venture capital trust, has agreed to significant cuts in management fees following deep dissatisfaction from shareholders incensed by poor returns. The trust’s board, after a protracted
AstraZeneca, the United Kingdom’s most valuable listed business, has announced a pause on its planned £200 million expansion at the Cambridge research hub, dealing a substantial setback to the government’s
Merck, the renowned US pharmaceuticals giant known as MSD across Europe, has abandoned plans for a £1 billion research centre in London—a significant blow for the UK life sciences sector.
An unexpected breakthrough by three British biologists could revolutionise the way breast milk is stored, presenting both health and commercial prospects for families and investors alike. BoobyBiome, a biotechnology start-up
Sir Jim Ratcliffe’s Ineos group has halted fresh investment in the United Kingdom and shifted its financial priorities to the United States, citing soaring energy costs and an unpredictable British
Coventry-based electric motorbike manufacturer Maeving has attracted an £8 million investment as it seeks to ramp up domestic and international production. The company, founded by Seb Inglis-Jones and Will Stirrup
Britain’s largest wind farm operator, Ørsted, is taking legal action against the US government after President Donald Trump halted its near-complete offshore wind project off the New England coast. The
One of Europe’s most influential pension funds has withdrawn a mandate valued at approximately €14.5 billion from BlackRock, citing growing concern over the US asset manager’s stance on sustainability and
Norway’s sovereign wealth fund, the largest in the world, has decided to divest its substantial £1.8bn holding in Caterpillar in response to ethical concerns regarding the use of the company’s
Wes Streeting, the new health secretary, has escalated his confrontation with leading pharmaceutical firms over the soaring cost of medicines and its impact on the UK’s broader life sciences sector.